FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2777857515> ?p ?o ?g. }

• W2777857515 endingPage "204" @default.
• W2777857515 startingPage "204" @default.
• W2777857515 abstract "Left ventricular assist devices (LVADs) are widely used both as a bridge to heart transplant and as destination therapy in advanced heart failure. Although heart failure is common in patients with end-stage renal disease (ESRD), little is known about outcomes after LVAD implantation in this population.To determine the utilization of and outcomes associated with LVADs in nationally representative cohorts of patients with and without ESRD.We described LVAD utilization and outcomes among Medicare beneficiaries after ESRD onset (defined as having received maintenance dialysis or a kidney transplant) from 2003 to 2013 based on Medicare claims linked to data from the United States Renal Data System (USRDS), a national registry for ESRD. We compared Medicare beneficiaries with ESRD to a 5% sample of Medicare beneficiaries without ESRD.ESRD (vs no ESRD) among patients who underwent LVAD placement.The primary outcome was survival after LVAD placement.Among the patients with ESRD, the mean age was 58.4 (12.1) years and 62.0% (96) were male. Among those without ESRD, the mean age was 62.2 (12.6) years and 75.1% (196) were male. From 2003 to 2013, 155 Medicare beneficiaries with ESRD (median and interquartile range [IQR] days from ESRD onset to LVAD placement were 1655 days [453-3050 days]) and 261 beneficiaries without ESRD in the Medicare 5% sample received an LVAD. During a median follow-up of 762 days (IQR, 92-3850 days), 127 patients (81.9%) with and 95 (36.4%) without ESRD died. more than half of patients with ESRD (80 [51.6%]) compared with 11 (4%) of those without ESRD died during the index hospitalization. The median time to death was 16 days (IQR 2-447 days) for patients with ESRD compared with 2125 days (IQR, 565-3850 days) for those without ESRD. With adjustment for demographics, comorbidity and time period, patients with ESRD had a markedly increased adjusted risk of death (hazard ratio, 36.3; 95% CI, 15.6-84.5), especially in the first 60 days after LVAD placement.Patients with ESRD at the time of LVAD placement had an extremely poor prognosis, with most surviving for less than 3 weeks. This information may be crucial in supporting shared decision-making around treatments for advanced heart failure for patients with ESRD." @default.
• W2777857515 created "2018-01-05" @default.
• W2777857515 creator A5022346670 @default.
• W2777857515 creator A5025681802 @default.
• W2777857515 creator A5033218952 @default.
• W2777857515 creator A5051161233 @default.
• W2777857515 creator A5054981295 @default.
• W2777857515 creator A5063116901 @default.
• W2777857515 creator A5085683611 @default.
• W2777857515 date "2018-02-01" @default.
• W2777857515 modified "2023-10-16" @default.
• W2777857515 title "Outcomes Associated With Left Ventricular Assist Devices Among Recipients With and Without End-stage Renal Disease" @default.
• W2777857515 cites W1968476479 @default.
• W2777857515 cites W1969563531 @default.
• W2777857515 cites W1977279748 @default.
• W2777857515 cites W1996785300 @default.
• W2777857515 cites W1997701104 @default.
• W2777857515 cites W1997780004 @default.
• W2777857515 cites W2023721091 @default.
• W2777857515 cites W2026009101 @default.
• W2777857515 cites W2031826031 @default.
• W2777857515 cites W2061326496 @default.
• W2777857515 cites W2066904707 @default.
• W2777857515 cites W2095140034 @default.
• W2777857515 cites W2110802587 @default.
• W2777857515 cites W2120115475 @default.
• W2777857515 cites W2157931911 @default.
• W2777857515 cites W2165719156 @default.
• W2777857515 cites W2169138421 @default.
• W2777857515 cites W2170431478 @default.
• W2777857515 cites W2196236374 @default.
• W2777857515 cites W2211981808 @default.
• W2777857515 cites W2212715385 @default.
• W2777857515 cites W2306523550 @default.
• W2777857515 cites W2313204009 @default.
• W2777857515 cites W2528714205 @default.
• W2777857515 cites W2536765920 @default.
• W2777857515 cites W2547841042 @default.
• W2777857515 cites W2559961378 @default.
• W2777857515 doi "https://doi.org/10.1001/jamainternmed.2017.4831" @default.
• W2777857515 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5801100" @default.
• W2777857515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29255896" @default.
• W2777857515 hasPublicationYear "2018" @default.
• W2777857515 type Work @default.
• W2777857515 sameAs 2777857515 @default.
• W2777857515 citedByCount "58" @default.
• W2777857515 countsByYear W27778575152018 @default.
• W2777857515 countsByYear W27778575152019 @default.
• W2777857515 countsByYear W27778575152020 @default.
• W2777857515 countsByYear W27778575152021 @default.
• W2777857515 countsByYear W27778575152022 @default.
• W2777857515 countsByYear W27778575152023 @default.
• W2777857515 crossrefType "journal-article" @default.
• W2777857515 hasAuthorship W2777857515A5022346670 @default.
• W2777857515 hasAuthorship W2777857515A5025681802 @default.
• W2777857515 hasAuthorship W2777857515A5033218952 @default.
• W2777857515 hasAuthorship W2777857515A5051161233 @default.
• W2777857515 hasAuthorship W2777857515A5054981295 @default.
• W2777857515 hasAuthorship W2777857515A5063116901 @default.
• W2777857515 hasAuthorship W2777857515A5085683611 @default.
• W2777857515 hasBestOaLocation W27778575151 @default.
• W2777857515 hasConcept C119060515 @default.
• W2777857515 hasConcept C126322002 @default.
• W2777857515 hasConcept C141071460 @default.
• W2777857515 hasConcept C164705383 @default.
• W2777857515 hasConcept C2778063415 @default.
• W2777857515 hasConcept C2778198053 @default.
• W2777857515 hasConcept C2778774980 @default.
• W2777857515 hasConcept C2779326848 @default.
• W2777857515 hasConcept C2779978075 @default.
• W2777857515 hasConcept C2908647359 @default.
• W2777857515 hasConcept C3019040382 @default.
• W2777857515 hasConcept C71924100 @default.
• W2777857515 hasConcept C99454951 @default.
• W2777857515 hasConceptScore W2777857515C119060515 @default.
• W2777857515 hasConceptScore W2777857515C126322002 @default.
• W2777857515 hasConceptScore W2777857515C141071460 @default.
• W2777857515 hasConceptScore W2777857515C164705383 @default.
• W2777857515 hasConceptScore W2777857515C2778063415 @default.
• W2777857515 hasConceptScore W2777857515C2778198053 @default.
• W2777857515 hasConceptScore W2777857515C2778774980 @default.
• W2777857515 hasConceptScore W2777857515C2779326848 @default.
• W2777857515 hasConceptScore W2777857515C2779978075 @default.
• W2777857515 hasConceptScore W2777857515C2908647359 @default.
• W2777857515 hasConceptScore W2777857515C3019040382 @default.
• W2777857515 hasConceptScore W2777857515C71924100 @default.
• W2777857515 hasConceptScore W2777857515C99454951 @default.
• W2777857515 hasIssue "2" @default.
• W2777857515 hasLocation W27778575151 @default.
• W2777857515 hasLocation W27778575152 @default.
• W2777857515 hasLocation W27778575153 @default.
• W2777857515 hasLocation W27778575154 @default.
• W2777857515 hasOpenAccess W2777857515 @default.
• W2777857515 hasPrimaryLocation W27778575151 @default.
• W2777857515 hasRelatedWork W113810927 @default.
• W2777857515 hasRelatedWork W2036455093 @default.
• W2777857515 hasRelatedWork W2125804349 @default.
• W2777857515 hasRelatedWork W2210731037 @default.

• next